Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA: EDIT-CMD
In a randomized trial of patients with angina and no obstructive Coronary artery disease(ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction — apart from epicardial spasm — or angina symptoms and quality of life. The trial investigated whether this therapy would improve these outcomes in patients with two endotypes of […]
Conference News